Gabapentin and Hyperventilation - a phase IV clinical study of FDA data

Summary:

Hyperventilation is reported as a side effect among people who take Gabapentin (gabapentin), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Cymbalta, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Hyperventilation when taking Gabapentin. It is created by eHealthMe based on reports of 313,421 people who have side effects when taking Gabapentin from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,962 Gabapentin users. Check the latest studies of Gabapentin.

What is Hyperventilation?

Hyperventilation is found to be associated with 799 drugs and 1,440 conditions by eHealthMe. Check the latest studies of Hyperventilation.

On Nov, 07, 2025

313,421 people reported to have side effects when taking Gabapentin.
Among them, 104 people (0.03%) have Hyperventilation.

Could Gabapentin cause Hyperventilation?

Among these 104 people:

How long have people been on Gabapentin when they have Hyperventilation? *

Click here to view more results

What is the gender of people who have Hyperventilation when taking Gabapentin? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gabapentin:

Gabapentin (322,962 reports)

Hyperventilation treatments and more:

Hyperventilation (8,309 reports)

How severe was Hyperventilation and when was it recovered:

Hyperventilation in Gabapentin

Expand to all the drugs that have ingredients of gabapentin:

Hyperventilation and drugs with ingredients of gabapentin (166 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Common Gabapentin side effects:

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Hyperventilation:

Browse all the drugs that are associated with Hyperventilation:

Hyperventilation (799 drugs)

Common conditions associated with Hyperventilation:

Browse all the conditions that are associated with Hyperventilation:

Hyperventilation (1,440 conditions)

Drugs similar to Gabapentin and Hyperventilation :

Lyrica side effect: Hyperventilation

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.